Jessica Frye: Understanding VTE in Pregnancy and the Postpartum Period
Jessica Frye, Traveling Labor and Delivery Nurse, shared a post on LinkedIn:
“Understanding Venous Thromboembolism (VTE) in Pregnancy and the Postpartum Period
Pregnancy is a hypercoagulable state, meaning the body naturally increases its ability to form blood clots in preparation for childbirth. While this helps reduce bleeding after delivery, it also increases the risk of venous thromboembolism (VTE) – one of the leading causes of preventable maternal morbidity and mortality.
VTE includes two potentially life-threatening conditions:
- Deep Vein Thrombosis (DVT) – A blood clot that most commonly develops in the deep veins of the legs or pelvis.
- Pulmonary Embolism (PE) – Occurs when part of a clot breaks free and travels to the lungs, blocking blood flow. A PE is a medical emergency and can be fatal.
Pregnancy-Related Risk Factors Include:
- Previous VTE
- Cesarean delivery
- Obesity
- Prolonged bed rest or immobility
- Preeclampsia or hypertensive disorders of pregnancy
- Multiple gestation
- Postpartum hemorrhage
- Thrombophilia (inherited or acquired clotting disorders)
- Maternal age greater than 35 years
- Smoking
Warning Signs of DVT
- Unilateral leg swelling
- Calf or thigh pain
- Warmth or redness of the affected extremity
Warning Signs of PE
- Sudden shortness of breath
- Chest pain
- Tachycardia
- Rapid breathing
- Syncope or near-syncope
Early recognition saves lives. Prompt assessment, diagnostic testing, anticoagulation when indicated, and appropriate postpartum thromboprophylaxis are critical to reducing maternal morbidity and mortality.
Birth injury attorneys: Were maternal risk factors identified?
Were warning signs recognized and escalated?
Was appropriate thromboprophylaxis or diagnostic evaluation considered during pregnancy or the postpartum period?”
Stay updated with Hemostasis Today.
-
Sep 17, 2026, 04:43Tom Tang: Preventing Post Thrombotic Syndrome Starts With Early DVT Prevention
-
Sep 17, 2026, 04:35Veronica Sanchez: Menopause as a Risk for Heart Disaese
-
Sep 17, 2026, 03:04Leonardo Roever: Exploring the Role of Glutamine Metabolism in Atherosclerosis
-
Sep 17, 2026, 02:36Wolfgang Miesbach: Effectiveness of Avatrombopag in ITP Treatment
-
Sep 17, 2026, 02:34Aleksandar Sič: The Endothelium and Cardiovascular Toxicity in Blood Cancers
-
Sep 16, 2026, 15:45Matthew Hazell: A Brilliant Explanation of Phenotype vs Genotype Using a LEGO House
-
Sep 16, 2026, 15:23Ahmad Al-Ramahi: Presenting the Military Pharmacists Blood Training Course at the FIP World Congress
-
Sep 16, 2026, 15:21HIT Reimagined: Can 12-Lipoxygenase Inhibition Stop Immune Thrombosis?
-
Sep 16, 2026, 14:42Ruchi Punamia: Beyond the Blood Bank and The Clinical Impact of Apheresis